IFAN — Palantir Bioceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: TIFIN Board Welcomes Palantir's Lila Flores as a New Member, enhancing its expertise AI Commercialization
Analysis: US tech-stock stumble shows vulnerability in AI trade
Analysis: US tech-stock stumble shows vulnerability in AI trade
Founders Fund in talks to back defense firm Anduril at $28 billion valuation, sources say (updated)
Ooredoo Group H1 2020 Financial Results
Ooredoo Group Q1 2019 Financial Results